NO20020084L - Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse - Google Patents

Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse

Info

Publication number
NO20020084L
NO20020084L NO20020084A NO20020084A NO20020084L NO 20020084 L NO20020084 L NO 20020084L NO 20020084 A NO20020084 A NO 20020084A NO 20020084 A NO20020084 A NO 20020084A NO 20020084 L NO20020084 L NO 20020084L
Authority
NO
Norway
Prior art keywords
sustained release
release compositions
salt
processes
preparation
Prior art date
Application number
NO20020084A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020084D0 (no
Inventor
Yasutaka Igari
Yoshio Hata
Kazumichi Yamamoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20020084D0 publication Critical patent/NO20020084D0/no
Publication of NO20020084L publication Critical patent/NO20020084L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20020084A 1999-07-15 2002-01-08 Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse NO20020084L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20188799 1999-07-15
PCT/JP2000/004683 WO2001005380A1 (fr) 1999-07-15 2000-07-13 Compositions a liberation lente, techniques de production et methodes d'utilisation

Publications (2)

Publication Number Publication Date
NO20020084D0 NO20020084D0 (no) 2002-01-08
NO20020084L true NO20020084L (no) 2002-03-14

Family

ID=16448493

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020084A NO20020084L (no) 1999-07-15 2002-01-08 Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse

Country Status (21)

Country Link
US (2) US7265157B1 (xx)
EP (1) EP1197208B1 (xx)
KR (1) KR20020012312A (xx)
CN (1) CN1361685A (xx)
AT (1) ATE360413T1 (xx)
AU (1) AU5853000A (xx)
BR (1) BR0012400A (xx)
CA (1) CA2378714A1 (xx)
CZ (1) CZ2002114A3 (xx)
DE (1) DE60034568T2 (xx)
HK (1) HK1042237A1 (xx)
HU (1) HUP0202880A3 (xx)
IL (1) IL147417A0 (xx)
MX (1) MXPA02000461A (xx)
NO (1) NO20020084L (xx)
NZ (1) NZ516466A (xx)
PL (1) PL352499A1 (xx)
RU (1) RU2002103718A (xx)
SK (1) SK342002A3 (xx)
WO (1) WO2001005380A1 (xx)
ZA (1) ZA200200347B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL341733A1 (en) 1998-01-16 2001-05-07 Takeda Chemical Industries Ltd Prolonged release composition, method of obtaining same and application thereof
WO2000035990A1 (fr) 1998-12-15 2000-06-22 Takeda Chemical Industries, Ltd. Procede de production d'un polymere
PT1693054T (pt) 2000-08-07 2016-07-07 Takeda Pharmaceuticals Co Polímero de ácido láctico e processo para a sua produção
US20040116522A1 (en) * 2001-03-30 2004-06-17 Yutaka Yamagata Medicinal solutions
CA2444727A1 (en) * 2001-04-25 2002-11-07 Takeda Chemical Industries, Ltd. Agents for preventing postoperative recurrence of premenopausal breast cancer
US6693134B2 (en) 2001-05-29 2004-02-17 Chemokine Therapeutics Corporation Bicyclic aromatic chemokine receptor ligands
TWI332407B (en) † 2001-06-29 2010-11-01 Takeda Chemical Industries Ltd Controlled release composition and method of producting the same
CN101444476B (zh) * 2001-12-26 2011-11-30 武田药品工业株式会社 新微球和其生产方法
US8088726B2 (en) 2002-06-25 2012-01-03 Takeda Pharmaceutical Company Limited Process for producing sustained-release composition
EP2444069B1 (en) * 2003-07-23 2019-06-05 Evonik Corporation Controlled release compositions
US7906125B2 (en) 2003-09-18 2011-03-15 Boston Scientific Scimed, Inc. Solid or semi-solid therapeutic formulations
US20050064045A1 (en) * 2003-09-18 2005-03-24 Sheng-Ping Zhong Injectable therapeutic formulations
TW200529890A (en) 2004-02-10 2005-09-16 Takeda Pharmaceutical Sustained-release preparations
EP1679065A1 (en) 2005-01-07 2006-07-12 OctoPlus Sciences B.V. Controlled release compositions for interferon based on PEGT/PBT block copolymers
US8263109B2 (en) 2005-05-09 2012-09-11 Boston Scientific Scimed, Inc. Injectable bulking compositions
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
EP1973558A4 (en) * 2005-12-13 2009-12-23 Harkness Pharmaceuticals Inc METHODS OF TREATING OBESITY WITH ENTEROSTATIN
US20070149457A1 (en) * 2005-12-13 2007-06-28 Byron Rubin Stable solid forms of enterostatin
EP2051725A4 (en) * 2006-07-11 2011-06-15 Harkness Pharmaceuticals Inc METHOD FOR THE TREATMENT OF GRAIN WITH SATURATION FACTORS
US7858663B1 (en) * 2007-10-31 2010-12-28 Pisgah Laboratories, Inc. Physical and chemical properties of thyroid hormone organic acid addition salts
CN101563068B (zh) 2006-12-18 2013-03-20 武田药品工业株式会社 缓释组合物和其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022786A1 (en) 1995-01-23 1996-08-01 Takeda Chemical Industries, Ltd. Sustained-release preparation and use
DK0839525T3 (da) 1996-10-31 2004-11-29 Takeda Pharmaceutical Præparat med forlænget frigivelse
AU5678398A (en) 1997-01-29 1998-08-18 Takeda Chemical Industries Ltd. Sustained-release microspheres, their production and use
PL341733A1 (en) * 1998-01-16 2001-05-07 Takeda Chemical Industries Ltd Prolonged release composition, method of obtaining same and application thereof
JPH11269094A (ja) * 1998-01-16 1999-10-05 Takeda Chem Ind Ltd 徐放性組成物、その製造法および用途
WO2000035990A1 (fr) 1998-12-15 2000-06-22 Takeda Chemical Industries, Ltd. Procede de production d'un polymere

Also Published As

Publication number Publication date
PL352499A1 (en) 2003-08-25
EP1197208A1 (en) 2002-04-17
CZ2002114A3 (cs) 2002-04-17
DE60034568T2 (de) 2008-01-03
CN1361685A (zh) 2002-07-31
KR20020012312A (ko) 2002-02-15
US20080014237A1 (en) 2008-01-17
EP1197208B1 (en) 2007-04-25
MXPA02000461A (es) 2002-07-30
CA2378714A1 (en) 2001-01-25
AU5853000A (en) 2001-02-05
ATE360413T1 (de) 2007-05-15
NZ516466A (en) 2003-02-28
ZA200200347B (en) 2003-03-26
HK1042237A1 (zh) 2002-08-09
US7265157B1 (en) 2007-09-04
SK342002A3 (en) 2002-05-09
EP1197208A4 (en) 2004-06-30
DE60034568D1 (de) 2007-06-06
IL147417A0 (en) 2002-08-14
RU2002103718A (ru) 2003-10-10
HUP0202880A3 (en) 2003-04-28
NO20020084D0 (no) 2002-01-08
BR0012400A (pt) 2002-05-21
HUP0202880A2 (hu) 2003-01-28
WO2001005380A1 (fr) 2001-01-25

Similar Documents

Publication Publication Date Title
NO20020084L (no) Vedvarende frigivelsessammensetninger, fremgangsmåter for fremstilling av disse, og anvendelse av disse
CY1117889T1 (el) Πολυμερες γαλακτικου οξεος και διεργασια για την παραγωγη αυτου
HUP0100221A2 (hu) Nyújtott hatású készítmény és eljárás az előállítására, valamint alkalmazása
WO2001019780A3 (de) Neuartige aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
HUP0400382A2 (hu) Késleltetett leadású készítmény és eljárás annak előállítására
WO2001019776A3 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
DK0839525T3 (da) Præparat med forlænget frigivelse
CA2005986A1 (en) Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
WO2000061568A3 (de) Mit zuckerresten substituierte 1,4-benzothiazepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO1999057301A8 (fr) Composes dont la structure comporte des derives d'acide glucuronique et des derives de glucosamine, leur procede de preparation et d'utilisation
MY142066A (en) Controlled release composition comprising lactic acid polymer, and method of producing the same
JP2000159790A5 (xx)
DK0808303T3 (da) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreceptorantagonister
IL131216A0 (en) Drugs inhibiting progress of pterygium and postoperative recurrence of the same
ATE307809T1 (de) Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung
EP2239270A3 (en) Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction
WO2002030874A3 (en) Aliphatic, cyclic amino carboxylic acids as integrin antagonists
JP4699635B2 (ja) 徐放性薬剤組成物
EE03522B1 (et) Meetod kinoloonkarboksüülhapete ja naftüridiinkarboksüülhapete saamiseks vabade aluste kujul
DE69908771D1 (de) Tilidin-mesylat, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen
JPS6452774A (en) Amide derivative, production thereof and plant disease controlling agent containing said derivative as active ingredient
TH27939B (th) สูตรส่วนผสมทางเภสัช
JPS6461478A (en) Amide derivative, production thereof and plant injury controlling agent containing said derivative as active ingredient

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application